ClinConnect ClinConnect Logo
Search / Trial NCT06996626

Real-time NOMA Evaluation

Launched by DAVID T HUANG · May 29, 2025

Trial Information

Current as of July 21, 2025

Recruiting

Keywords

ClinConnect Summary

The Real-time NOMA Evaluation trial is looking at how an advanced system can help doctors provide better care in intensive care units (ICUs). This system monitors electronic health records (EHR) constantly and sends real-time alerts when it detects unusual behavior by healthcare providers. The goal is to see if these alerts can improve how doctors respond to patients at the bedside, potentially leading to better outcomes for critically ill patients.

This study will include all patients admitted to the ICUs at Presbyterian and Montefiore hospitals, so if you or a loved one is receiving care there, you may be eligible to participate. The trial is still in the planning stages and hasn't started recruiting participants yet. If you join, you can expect to be part of an important effort to enhance patient care through technology, with no specific exclusions for participation.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients in the Presbyterian and Montefiore ICUs
  • Exclusion Criteria:
  • None

About David T Huang

David T. Huang is a distinguished clinical trial sponsor known for his commitment to advancing medical research and improving patient outcomes. With extensive experience in clinical trial design and execution, he focuses on innovative therapies and interventions across various therapeutic areas. His collaborative approach fosters partnerships with healthcare professionals and institutions, ensuring rigorous adherence to regulatory standards and ethical practices. Through a dedication to scientific excellence and patient-centered care, David T. Huang aims to contribute significantly to the evolving landscape of clinical research and therapeutic advancements.

Locations

Pittsburgh, Pennsylvania, United States

Pittsburgh, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

David Huang, MD

Principal Investigator

University of Pittsburgh

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported